• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与人类细胞相比,中国仓鼠(啮齿动物)细胞的内在多药耐药表型。

Intrinsic multidrug resistance phenotype of Chinese hamster (rodent) cells in comparison to human cells.

作者信息

Gupta R S

机构信息

McMaster University, Department of Biochemistry, Hamilton, Ontario, Canada.

出版信息

Biochem Biophys Res Commun. 1988 Jun 16;153(2):598-605. doi: 10.1016/s0006-291x(88)81137-9.

DOI:10.1016/s0006-291x(88)81137-9
PMID:3382391
Abstract

In comparison to human cells, cell lines of Chinese hamster and mouse origin exhibit between 10-50-fold resistance to a number of different drugs (viz. actinomycin D, daunomycin, chromomycin A3, colchicine, maytansine, mithramycin, puromycin, rhodamine 123, vinblastine and taxol). Studies with a representative Chinese hamster line (CHO) and a single-step multidrug resistant (MDR) mutant of human (HeLa) cells show that: (i) In comparison to the sensitive human cells, both cell lines show a comparable degree of resistance to the above mentioned drugs; (ii) In the presence of non-toxic dosage of verapamil, the drug-resistance phenotype of both cell lines is completely reversed; (iii) Both these cell lines showed greatly reduced uptake/intracellular levels of 3H-daunomycin, 3H-puromycin and 3H-vinblastine, which was restored to sensitive human cell's level in the presence of non-toxic doses of verapamil. The striking similarity in the behaviour of the naturally resistant Chinese hamster cells and a human MDR cell line with regard to the above characteristics, strongly suggests that the species-related differences in sensitivity to the above drugs result from a similar mechanism as that responsible for the MDR phenotype.

摘要

与人类细胞相比,源自中国仓鼠和小鼠的细胞系对多种不同药物(即放线菌素D、柔红霉素、色霉素A3、秋水仙碱、美登素、光神霉素、嘌呤霉素、罗丹明123、长春碱和紫杉醇)表现出10至50倍的耐药性。对一个具有代表性的中国仓鼠细胞系(CHO)和人类(HeLa)细胞的单步多药耐药(MDR)突变体进行的研究表明:(i)与敏感的人类细胞相比,这两种细胞系对上述药物表现出相当程度的耐药性;(ii)在无毒剂量的维拉帕米存在下,这两种细胞系的耐药表型完全逆转;(iii)这两种细胞系对3H-柔红霉素、3H-嘌呤霉素和3H-长春碱的摄取/细胞内水平大大降低,在无毒剂量的维拉帕米存在下恢复到敏感人类细胞的水平。天然耐药的中国仓鼠细胞和人类MDR细胞系在上述特征方面行为的惊人相似性,强烈表明物种对上述药物敏感性的差异源于与MDR表型相同的机制。

相似文献

1
Intrinsic multidrug resistance phenotype of Chinese hamster (rodent) cells in comparison to human cells.与人类细胞相比,中国仓鼠(啮齿动物)细胞的内在多药耐药表型。
Biochem Biophys Res Commun. 1988 Jun 16;153(2):598-605. doi: 10.1016/s0006-291x(88)81137-9.
2
Cross resistance pattern towards anticancer drugs of a human carcinoma multidrug-resistant cell line.人癌多药耐药细胞系对抗癌药物的交叉耐药模式
Br J Cancer. 1988 Oct;58(4):441-7. doi: 10.1038/bjc.1988.237.
3
Reversal of intrinsic multidrug resistance in Chinese hamster ovary cells by amiloride analogs.阿米洛利类似物对中国仓鼠卵巢细胞内在多药耐药性的逆转作用。
Br J Cancer. 1991 Feb;63(2):247-51. doi: 10.1038/bjc.1991.58.
4
Species-specific differences in the toxicity of puromycin towards cultured human and Chinese hamster cells.嘌呤霉素对培养的人细胞和中国仓鼠细胞毒性的种属特异性差异。
FEBS Lett. 1988 Jul 4;234(1):141-4. doi: 10.1016/0014-5793(88)81320-6.
5
Species-specific differences in toxicity of antimitotic agents toward cultured mammalian cells.抗有丝分裂剂对培养哺乳动物细胞毒性的种属特异性差异。
J Natl Cancer Inst. 1985 Jan;74(1):159-64.
6
Action of calcium antagonists on multidrug resistant cells. Specific cytotoxicity independent of increased cancer drug accumulation.钙拮抗剂对多药耐药细胞的作用。特异性细胞毒性,与癌症药物蓄积增加无关。
Biochem Pharmacol. 1987 Jul 1;36(13):2115-23. doi: 10.1016/0006-2952(87)90139-0.
7
Characterization of actinomycin-D-resistant CHO cell lines exhibiting a multidrug-resistance phenotype and amplified DNA sequences.表现出多药耐药表型并具有扩增DNA序列的放线菌素D耐药CHO细胞系的特性分析
Int J Cancer. 1987 Nov 15;40(5):635-42. doi: 10.1002/ijc.2910400511.
8
Cross-resistance of vinblastine- and taxol-resistant mutants of Chinese hamster ovary cells to other anticancer drugs.中国仓鼠卵巢细胞长春碱和紫杉醇耐药突变体对其他抗癌药物的交叉耐药性。
Cancer Treat Rep. 1985 May;69(5):515-21.
9
Characterization of multidrug-resistant pituitary tumor cells.
Endocrinology. 1992 Jun;130(6):3246-56. doi: 10.1210/endo.130.6.1350759.
10
Single cell analysis of daunomycin uptake and efflux in multidrug-resistant and -sensitive KB cells: effects of verapamil and other drugs.多药耐药和敏感KB细胞中柔红霉素摄取与外排的单细胞分析:维拉帕米及其他药物的作用
Cancer Res. 1986 Nov;46(11):5941-6.

引用本文的文献

1
Using a competitive counterflow assay to identify novel cationic substrates of OATP1B1 and OATP1B3.使用竞争性逆流测定法来鉴定有机阴离子转运多肽1B1(OATP1B1)和有机阴离子转运多肽1B3(OATP1B3)的新型阳离子底物。
Front Physiol. 2022 Sep 8;13:969363. doi: 10.3389/fphys.2022.969363. eCollection 2022.
2
Sensitive and specific fluorescent probes for functional analysis of the three major types of mammalian ABC transporters.用于三种主要类型的哺乳动物 ABC 转运蛋白的功能分析的敏感和特异的荧光探针。
PLoS One. 2011;6(7):e22429. doi: 10.1371/journal.pone.0022429. Epub 2011 Jul 22.
3
Small molecules that dramatically alter multidrug resistance phenotype by modulating the substrate specificity of P-glycoprotein.
通过调节P-糖蛋白的底物特异性来显著改变多药耐药表型的小分子。
Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):14078-83. doi: 10.1073/pnas.241314798. Epub 2001 Nov 13.
4
Dipyridamole increases VP16 growth inhibition, accumulation and retention in parental and multidrug-resistant CHO cells.双嘧达莫增强了依托泊苷对亲代及多药耐药的中国仓鼠卵巢细胞的生长抑制、蓄积和滞留作用。
Br J Cancer. 1996 Apr;73(7):856-60. doi: 10.1038/bjc.1996.152.
5
Differential modulation of doxorubicin toxicity to multidrug and intrinsically drug resistant cell lines by anti-oestrogens and their major metabolites.抗雌激素及其主要代谢产物对阿霉素对多药耐药和固有耐药细胞系毒性的差异调节作用。
Br J Cancer. 1993 Jun;67(6):1189-95. doi: 10.1038/bjc.1993.224.
6
Investigation of the relationship between altered intracellular pH and multidrug resistance in mammalian cells.哺乳动物细胞内pH值改变与多药耐药性之间关系的研究。
Br J Cancer. 1990 Apr;61(4):568-72. doi: 10.1038/bjc.1990.127.
7
Reversal of intrinsic multidrug resistance in Chinese hamster ovary cells by amiloride analogs.阿米洛利类似物对中国仓鼠卵巢细胞内在多药耐药性的逆转作用。
Br J Cancer. 1991 Feb;63(2):247-51. doi: 10.1038/bjc.1991.58.